455 Tianda Pharmaceuticals Ltd. HKEX · Hong Kong

Tianda Pharmaceuticals (455) news

Tianda Pharmaceuticals Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 455, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Tianda Pharmaceuticals news

We have not published a story on Tianda Pharmaceuticals yet. When there is news, it will appear here.

Questions about Tianda Pharmaceuticals

What is the ticker symbol of Tianda Pharmaceuticals?

Tianda Pharmaceuticals Ltd. trades under the ticker 455 on HKEX.

Where is Tianda Pharmaceuticals listed?

Tianda Pharmaceuticals Ltd. is listed on HKEX.

Which country or territory is Tianda Pharmaceuticals listed under?

Our directory records Tianda Pharmaceuticals Ltd. under Hong Kong.

What does Tianda Pharmaceuticals do?

Our directory classifies Tianda Pharmaceuticals Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Tianda Pharmaceuticals?

The ISIN recorded for Tianda Pharmaceuticals Ltd. is KYG887471038.

Does aibio.space cover Tianda Pharmaceuticals?

aibio.space lists Tianda Pharmaceuticals Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Tianda Pharmaceuticals?

Companies in our directory listed in the same country and business area as Tianda Pharmaceuticals: China Biotech Services Holdings, SSY Group, Extrawell Pharmaceutical Holdings, China Resources Pharmaceutical Group, HUTCHMED (China), Pak Fah Yeow International.

Investor discussion: Tianda Pharmaceuticals

Members talk about Tianda Pharmaceuticals (455). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Tianda Pharmaceuticals, newest first. Each line links the filing it comes from.

Apr 29, 2026Financings
Share or debt issue: PROPOSALS INVOLVING GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; RE-ELECTION OF RETIRING DIRECTORS; RE-APPOINTMENT OF AUDITOR; AND NOTICE OF ANNUAL GENERAL MEETING. Source
Apr 30, 2025Financings
Share or debt issue: PROPOSALS INVOLVING GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; RE-ELECTION OF RETIRING DIRECTORS; AND NOTICE OF ANNUAL GENERAL MEETING. Source

Press releases

Headlines of Tianda Pharmaceuticals's own announcements, newest first. Each opens the full release on the newswire that carried it.

Sep 29, 2026HKEXnews
Notification Letter and Request Form to Non-Registered Shareholders
Sep 29, 2026HKEXnews
Notification Letter and Reply Form to Registered Shareholders
Aug 10, 2026HKEXnews
2026 INTERIM RESULTS ANNOUNCEMENT
Jun 12, 2026HKEXnews
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 12 JUNE 2026
Apr 29, 2026HKEXnews
NOTICE OF ANNUAL GENERAL MEETING
Apr 29, 2026HKEXnews
PROPOSALS INVOLVING GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; RE-ELECTION OF RETIRING DIRECTORS; RE-APPOINTMENT OF AUDITOR; AND NOTICE OF ANNUAL GENERAL MEETING
Apr 29, 2026HKEXnews
CLOSURES OF REGISTER OF MEMBERS
Mar 26, 2026HKEXnews
FINAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025
Aug 28, 2025HKEXnews
CHANGE OF NON-EXECUTIVE DIRECTOR
Aug 28, 2025HKEXnews
2025 INTERIM RESULTS ANNOUNCEMENT
Jul 23, 2025HKEXnews
CHANGE OF HONG KONG SHARE REGISTRAR AND TRANSFER OFFICE
Jun 27, 2025HKEXnews
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE
Jun 27, 2025HKEXnews
CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE AND DESIGNATION OF LEAD INDEPENDENT NON-EXECUTIVE DIRECTOR
Jun 13, 2025HKEXnews
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 13 JUNE 2025
Apr 30, 2025HKEXnews
Notification Letter
Apr 30, 2025HKEXnews
PROPOSALS INVOLVING GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; RE-ELECTION OF RETIRING DIRECTORS; AND NOTICE OF ANNUAL GENERAL MEETING
Mar 28, 2025HKEXnews
FINAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024
Mar 25, 2025HKEXnews
PROFIT WARNING
Dec 18, 2024HKEXnews
(I) REVISION OF EXPIRY DATE FOR EXISTING CONTINUING CONNECTED TRANSACTION WITH TCH (CHINA) GROUP AND (II) RENEWAL OF FRAMEWORK AGREEMENT WITH TCH (CHINA) GROUP

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:455 on TradingView.

Listing details

Company: Tianda Pharmaceuticals Ltd.
Ticker: 455
Listing: HKEX
Country or territory: Hong Kong
Business scope: Pharmaceuticals: Major
ISIN: KYG887471038
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction